{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:34:50Z","timestamp":1784219690538,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["24K10538"],"award-info":[{"award-number":["24K10538"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["JPJ012425"],"award-info":[{"award-number":["JPJ012425"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022743","name":"Jichi Medical University Hospital","doi-asserted-by":"publisher","award":["22-082"],"award-info":[{"award-number":["22-082"]}],"id":[{"id":"10.13039\/100022743","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006092","name":"Foundation for Development of Community","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006092","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijid.2025.108043","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T15:55:44Z","timestamp":1756828544000},"page":"108043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Trends in the healthcare burden of hepatitis C after the introduction of direct-acting antivirals in Japan, 2013-2022: A national claims database study in Japan"],"prefix":"10.1016","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4963-9587","authenticated-orcid":false,"given":"Shimpei","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Mitsutake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2684-1695","authenticated-orcid":false,"given":"Shuji","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.108043_bib0002","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1002\/hep.29707","article-title":"The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: an ERCHIVES study","volume":"67","author":"Li","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ijid.2025.108043_bib0003","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jhep.2017.07.025","article-title":"Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression","volume":"67","author":"Waziry","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2025.108043_bib0004","article-title":"HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma","author":"Ioannou","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2025.108043_bib0005","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.3748\/wjg.v26.i43.6770","article-title":"Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: a debate near the end","volume":"26","author":"Muzica","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijid.2025.108043_bib0006","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41598-021-03272-1","article-title":"Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents","volume":"12","author":"Yoo","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2025.108043_bib0007","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/hep.30303","article-title":"Impact of all-oral direct-acting antivirals on clinical and economic outcomes in patients with chronic hepatitis C in the United States","volume":"69","author":"Park H","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ijid.2025.108043_bib0008","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/jvh.13295","article-title":"The impact of SVR from direct-acting antiviral- and interferon-based treatments for HCV on hepatocellular carcinoma risk","volume":"27","author":"Janjua","year":"2020","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ijid.2025.108043_bib0009","doi-asserted-by":"crossref","first-page":"28","DOI":"10.37737\/ace.1.2_28","article-title":"Real world data in Japan. Chapter I NDB","volume":"1","author":"Yasunaga","year":"2019","journal-title":"Ann Clin Epidemiol"},{"key":"10.1016\/j.ijid.2025.108043_bib0010","article-title":"Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: a simulation study","volume":"22","author":"Tanaka","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.ijid.2025.108043_bib0011","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jhep.2022.09.011","article-title":"National trends in retreatment of HCV due to reinfection or treatment failure in Australia","volume":"78","author":"Carson","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2025.108043_bib0012","doi-asserted-by":"crossref","first-page":"321","DOI":"10.35772\/ghm.2021.01083","article-title":"Treatment progress and expansion in Japan: from interferon to direct-acting antiviral","volume":"3","author":"Tahata","year":"2021","journal-title":"Glob Health Med"},{"key":"10.1016\/j.ijid.2025.108043_sbref0013","series-title":"Global hepatitis report 2024: action for access in low- and middle-income countries","year":"2024"},{"key":"10.1016\/j.ijid.2025.108043_bib0014","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/liv.15875","article-title":"Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection","volume":"44","author":"Forouzannia","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.ijid.2025.108043_bib0015","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3390\/v14040790","article-title":"Elimination of HCV in Russia: barriers and perspective","volume":"14","author":"Isakov","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2025.108043_bib0016","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2957\/kanzo.57.634","article-title":"Study of the issues of receiving hepatitis screening and the rate of consulting hospitals\u2014the rate of recognized receiving hepatitis screening and that of the unrecognized","volume":"57","author":"Kaishima","year":"2016","journal-title":"Kanzo"},{"key":"10.1016\/j.ijid.2025.108043_bib0017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12879-022-07152-5","article-title":"Prevalence of HIV infection among non-elderly individuals with hepatitis C in Japan: a population-based cohort study using a health insurance claim data","volume":"22","author":"Ikeuchi","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2025.108043_sbref0018","series-title":"Epidemiological and molecular biological study of HCV infection among drug users and MSM towards HCV eradication","author":"Tanaka","year":"2022"},{"key":"10.1016\/j.ijid.2025.108043_bib0019","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1017\/S0950268823001772","article-title":"Injection drug use and sexually transmitted infections among men who have sex with men: a retrospective cohort study at an HIV\/AIDS referral hospital in Tokyo, 2013-2022","volume":"151","author":"Ikeuchi","year":"2023","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijid.2025.108043_bib0020","doi-asserted-by":"crossref","first-page":"e3266","DOI":"10.1093\/cid\/ciaa1940","article-title":"Microelimination or not? The changing epidemiology of human immunodeficiency virus-hepatitis C virus coinfection in France 2012-2018","volume":"73","author":"Cotte","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2025.108043_bib0021","doi-asserted-by":"crossref","first-page":"262","DOI":"10.35772\/ghm.2021.01069","article-title":"Epidemiology of viral hepatitis C: road to elimination in Japan","volume":"3","author":"Ko","year":"2021","journal-title":"Glob Health Med"},{"key":"10.1016\/j.ijid.2025.108043_bib0022","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/s41598-022-05444-z","article-title":"Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019","volume":"12","author":"Nakano","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2025.108043_bib0023","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s12072-020-10105-2","article-title":"HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort","volume":"14","author":"Tanaka","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ijid.2025.108043_bib0024","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.3390\/v13112249","article-title":"A review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy","volume":"13","author":"Mazzaro","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2025.108043_bib0025","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/hepr.13478","article-title":"Estimating the cost-effectiveness of screening for hepatitis C virus infection in Japan","volume":"50","author":"Nagai","year":"2020","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ijid.2025.108043_bib0026","article-title":"Assessment of the cost-effectiveness of Australia\u2019s risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study","volume":"18","author":"Scott","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.ijid.2025.108043_bib0027","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1007\/s12325-020-01492-x","article-title":"The economic value of improved productivity from treatment of chronic hepatitis C virus infection: a retrospective analysis of earnings, work loss, and health insurance data","volume":"37","author":"Sulkowski","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.ijid.2025.108043_bib0028","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/cid\/ciad425","article-title":"Temporal trends in hepatitis C-related hospitalizations, United States, 2000-2019","volume":"77","author":"Hofmeister","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2025.108043_bib0029","doi-asserted-by":"crossref","first-page":"150","DOI":"10.14745\/ccdr.v44i78a01","article-title":"Impact of availability of direct-acting antivirals for hepatitis C on Canadian hospitalization rates, 2012-2016","volume":"44","author":"Schanzer","year":"2018","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.ijid.2025.108043_bib0030","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/MEG.0000000000001195","article-title":"Treatment of hepatitis C with direct-acting antivirals significantly reduces liver-related hospitalizations in patients with cirrhosis","volume":"30","author":"Hill","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225002656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225002656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T02:11:33Z","timestamp":1762481493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225002656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":29,"alternative-id":["S1201971225002656"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108043","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in the healthcare burden of hepatitis C after the introduction of direct-acting antivirals in Japan, 2013-2022: A national claims database study in Japan","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108043"}}